213 related articles for article (PubMed ID: 14982147)
1. In silico predictive metabolism: a structural/electronic filter method.
Harris DL
Curr Opin Drug Discov Devel; 2004 Jan; 7(1):43-8. PubMed ID: 14982147
[TBL] [Abstract][Full Text] [Related]
2. Designing better drugs: predicting cytochrome P450 metabolism.
de Groot MJ
Drug Discov Today; 2006 Jul; 11(13-14):601-6. PubMed ID: 16793528
[TBL] [Abstract][Full Text] [Related]
3. Structure-based drug metabolism predictions for drug design.
Sun H; Scott DO
Chem Biol Drug Des; 2010 Jan; 75(1):3-17. PubMed ID: 19878193
[TBL] [Abstract][Full Text] [Related]
4. MetaSite: understanding metabolism in human cytochromes from the perspective of the chemist.
Cruciani G; Carosati E; De Boeck B; Ethirajulu K; Mackie C; Howe T; Vianello R
J Med Chem; 2005 Nov; 48(22):6970-9. PubMed ID: 16250655
[TBL] [Abstract][Full Text] [Related]
5. Human P450s involved in drug metabolism and the use of structural modelling for understanding substrate selectivity and binding affinity.
Lewis DF; Ito Y
Xenobiotica; 2009 Aug; 39(8):625-35. PubMed ID: 19514836
[TBL] [Abstract][Full Text] [Related]
6. Promiscuity: what protects us, perplexes us.
Redinbo MR
Drug Discov Today; 2004 May; 9(10):431-2. PubMed ID: 15109946
[No Abstract] [Full Text] [Related]
7. In silico toxicology for the pharmaceutical sciences.
Valerio LG
Toxicol Appl Pharmacol; 2009 Dec; 241(3):356-70. PubMed ID: 19716836
[TBL] [Abstract][Full Text] [Related]
8. High confidence predictions of drug-drug interactions: predicting affinities for cytochrome P450 2C9 with multiple computational methods.
Hudelson MG; Ketkar NS; Holder LB; Carlson TJ; Peng CC; Waldher BJ; Jones JP
J Med Chem; 2008 Feb; 51(3):648-54. PubMed ID: 18211009
[TBL] [Abstract][Full Text] [Related]
9. Human CYPs involved in drug metabolism: structures, substrates and binding affinities.
Lewis DF; Ito Y
Expert Opin Drug Metab Toxicol; 2010 Jun; 6(6):661-74. PubMed ID: 20402561
[TBL] [Abstract][Full Text] [Related]
10. Predicting ADME properties and side effects: the BioPrint approach.
Krejsa CM; Horvath D; Rogalski SL; Penzotti JE; Mao B; Barbosa F; Migeon JC
Curr Opin Drug Discov Devel; 2003 Jul; 6(4):470-80. PubMed ID: 12951810
[TBL] [Abstract][Full Text] [Related]
11. In silico human and rat Vss quantitative structure-activity relationship models.
Gleeson MP; Waters NJ; Paine SW; Davis AM
J Med Chem; 2006 Mar; 49(6):1953-63. PubMed ID: 16539383
[TBL] [Abstract][Full Text] [Related]
12. Do Fukui function maxima relate to sites of metabolism? A critical case study.
Beck ME
J Chem Inf Model; 2005; 45(2):273-82. PubMed ID: 15807488
[TBL] [Abstract][Full Text] [Related]
13. Building predictive ADMET models for early decisions in drug discovery.
Penzotti JE; Landrum GA; Putta S
Curr Opin Drug Discov Devel; 2004 Jan; 7(1):49-61. PubMed ID: 14982148
[TBL] [Abstract][Full Text] [Related]
14. Clustering and its application in multi-target prediction.
Liu W; Johnson DE
Curr Opin Drug Discov Devel; 2009 Jan; 12(1):98-107. PubMed ID: 19152218
[TBL] [Abstract][Full Text] [Related]
15. Using in vitro human tissues to predict pharmacokinetic properties.
Huebert ND; Dasgupta M; Chen Y
Curr Opin Drug Discov Devel; 2004 Jan; 7(1):69-74. PubMed ID: 14982150
[TBL] [Abstract][Full Text] [Related]
16. Substrate selectivity of drug-metabolizing cytochrome P450s predicted from crystal structures and in silico modeling.
Dong D; Wu B; Chow D; Hu M
Drug Metab Rev; 2012 May; 44(2):192-208. PubMed ID: 22251142
[TBL] [Abstract][Full Text] [Related]
17. Compound lipophilicity for substrate binding to human P450s in drug metabolism.
Lewis DF; Jacobs MN; Dickins M
Drug Discov Today; 2004 Jun; 9(12):530-7. PubMed ID: 15183161
[TBL] [Abstract][Full Text] [Related]
18. Hologram QSAR model for the prediction of human oral bioavailability.
Moda TL; Montanari CA; Andricopulo AD
Bioorg Med Chem; 2007 Dec; 15(24):7738-45. PubMed ID: 17870541
[TBL] [Abstract][Full Text] [Related]
19. The complexities inherent in attempts to decrease drug clearance by blocking sites of CYP-mediated metabolism.
Fisher MB; Henne KR; Boer J
Curr Opin Drug Discov Devel; 2006 Jan; 9(1):101-9. PubMed ID: 16445122
[TBL] [Abstract][Full Text] [Related]
20. Prediction of drug-like molecular properties: modeling cytochrome p450 interactions.
Jalaie M; Arimoto R; Gifford E; Schefzick S; Waller CL
Methods Mol Biol; 2004; 275():449-520. PubMed ID: 15141126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
